Americans Will Experience Reduced Costs of Inhalers For Asthma Medications at $35 Per Month parentherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from parentherald.com Daily Mail and Mail on Sunday newspapers.
On April 30, the Federal Trade Commission (FTC) announced that it was expanding its campaign against allegedly improper patent listings in the U.S. Food & Drug Administration’s (FDA) Orange Book.
Overview of the Recent Portfolio Addition Renaissance Technologies, led by Jim Simons (Trades, Portfolio), has recently expanded its investment portfolio with the addition of 4,144,447 shares in Innoviva Inc (NASDAQ:INVA). The transaction, which took place on December 29, 2023, reflects a 3.63% increase from the previous holding, marking a significant vote of confidence in the biopharmaceutical company. With a trade price of $16.04 per share, the firm has demonstrated a strategic move to capitalize on Innoviva's market potential.